scholarly article | Q13442814 |
P50 | author | Harvey White | Q1587897 |
Philippe Gabriel Steg | Q16027739 | ||
Hugo A. Katus | Q27929168 | ||
Kenneth Dickstein | Q43248428 | ||
Michał Tendera | Q48860774 | ||
Erik Magnus Ohman | Q60697402 | ||
L Kristin Newby | Q77796327 | ||
A. John Camm | Q110902795 | ||
P2093 | author name string | S. G. Priori | |
J. Morais | |||
R. De Caterina | |||
R. Harrington | |||
A. Vahanian | |||
P. Pais | |||
K. M. Fox | |||
P. A. Poole-Wilson | |||
G. A. Beller | |||
A. S. Jaffe | |||
B. F. Uretsky | |||
W. B. Gibler | |||
D. O. Williams | |||
J. S. Alpert | |||
C. W. Hamm | |||
P. W. Armstrong | |||
A. N. Parkhomenko | |||
U. Sechtem | |||
M. Lim | |||
C. Funck-Brentano | |||
G. Filippatos | |||
J. J. Bax | |||
K. McGregor | |||
M. Tubaro | |||
P. Widimsky | |||
S. D. Kristensen | |||
V. Dean | |||
R. Underwood | |||
D. Morrow | |||
M. L. Simoons | |||
K. Thygesen | |||
F. Fernandez-Aviles | |||
E. M. Antman | |||
D. Goff | |||
K. A. Fox | |||
T. B. Ferguson | |||
G. N. Levine | |||
W. Wijns | |||
L.-M. Voipio-Pulkki | |||
E. E. Van Der Wall | |||
S. Silber | |||
B. Chaitman | |||
R. Bonow | |||
F. S. Apple | |||
S. Mendis | |||
J. L. Zamorano | |||
D. Dudek | |||
E. P. Gurfinkel | |||
H. Hod | |||
I. Hellemans | |||
J. Ravkilde | |||
J.-L. Lopez-Sendon | |||
J.-P. Bassand | |||
J.-R. Zhu | |||
L. C. Wallentin | |||
M. A. Martinez-Rios | |||
M. Dellborg | |||
M. Galvani | |||
N. Al-Attar | |||
P. M. Clemmensen | |||
P. Porela | |||
S. Brener | |||
S. Steinhubl | |||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 2525-2538 | |
P577 | publication date | 2007-09-07 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | |
P478 | volume | 28 |
Q95417637 | Q95417637 |
Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
Q93017033 | 24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity |
Q57037490 | A Priori–Defined Dietary Patterns Are Associated with Reduced Risk of Stroke in a Large Italian Cohort |
Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
Q33638409 | A case report of spinal dural arteriovenous fistula: origins, determinants, and consequences of abnormal vascular malformations |
Q54367778 | A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population. |
Q64079704 | A circulating miRNA signature for early diagnosis of acute kidney injury following acute myocardial infarction |
Q33824669 | A comparison of off-pump and on-pump coronary bypass surgery in patients with low EuroSCORE |
Q46059674 | A multicentre analysis of troponin use in clinical practice |
Q35052889 | A new generation of biomarkers tests of myocardial necrosis: the real quality a physician can get from the laboratory |
Q40002380 | A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score. |
Q39654691 | A possible association between space weather conditions and the risk of acute coronary syndrome in patients with diabetes and the metabolic syndrome |
Q40107092 | A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases |
Q39363411 | A rapid, direct, quantitative, and label-free detector of cardiac biomarker troponin T using near-infrared fluorescent single-walled carbon nanotube sensors. |
Q37874799 | A review of interventions aimed at reducing pre-hospital delay time in acute coronary syndrome: what has worked and why? |
Q38466780 | A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease |
Q38657532 | A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. |
Q42966181 | A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes |
Q37140988 | ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction. |
Q39910247 | Accuracy of EASI 12-lead ECGs in monitoring ST-segment and J-point by nurses in the Coronary Care Units |
Q52381871 | Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in italy. |
Q43226804 | Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis |
Q34785177 | Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs |
Q43103704 | Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response |
Q43778043 | Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events |
Q51373718 | Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes. |
Q54069247 | Acute myocardial infarction |
Q34272594 | Acute myocardial infarction associated to DPP-4 inhibitors |
Q48401055 | Acute myocardial infarction complicated by shock: outcome analysis based on initial electrocardiogram |
Q34628066 | Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. |
Q40208516 | Acute-phase proteins and oxidative stress in patients undergoing coronary artery bypass graft: comparison of cardioplegia strategy |
Q86206726 | Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention |
Q24187926 | Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction |
Q24202298 | Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction |
Q34111144 | Adenosine diphosphate–induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events |
Q37463255 | Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome |
Q40495177 | Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction. Treatment regimens in German chest pain units |
Q44769587 | Age-specific 99th percentile cutoff of high-sensitivity cardiac troponin T for early prediction of non-ST-segment elevation myocardial infarction (NSTEMI) in middle-aged patients. |
Q95841288 | Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration |
Q36669772 | An algorithm that identifies coronary and heart failure events in the electronic health record |
Q58897839 | An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports |
Q58897834 | An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports |
Q43180190 | An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. |
Q40160496 | An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography. |
Q48163488 | An investigation of the independent risk factors that differentiate gout from pseudogout in patients with crystal-induced acute arthritis: a cross-sectional study. |
Q42662070 | An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy |
Q48191598 | An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents. |
Q85167019 | Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population |
Q35670653 | Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction |
Q33738712 | Anemia in critical illness: insights into etiology, consequences, and management |
Q34508351 | Animal models of cardiac disease and stem cell therapy |
Q39323874 | Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review |
Q83163607 | Anxiety trait in patients with stress-induced cardiomyopathy: a case-control study |
Q59783098 | Análisis crítico y propuestas de mejora de los sistemas de información sobre enfermedades cardiovasculares en España |
Q42270434 | Aortic dissection with concomitant acute myocardial infarction: From diagnosis to management |
Q34295833 | Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells |
Q42957452 | Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population |
Q38264294 | Application of microRNAs in diagnosis and treatment of cardiovascular disease |
Q54594382 | Artificial-epitope mapping for CK-MB assay. |
Q34561285 | Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology |
Q37685626 | Assessment of the management of acute myocardial infarction patients and their outcomes at the Nairobi Hospital from January 2007 to June 2009. |
Q36633686 | Association Between Smoking and Physician-Diagnosed Stroke and Myocardial Infarction in Male Adults in Korea |
Q36675776 | Association between frailty, cerebral oxygenation and adverse post-operative outcomes in elderly patients undergoing non-cardiac surgery: An observational pilot study |
Q50955829 | Association between periodontitis and acute myocardial infarction: a case-control study of a nondiabetic population. |
Q36283703 | Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography |
Q36058977 | Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population. |
Q58573294 | Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarction |
Q33970602 | Atrial fibrillation and the risk of myocardial infarction |
Q45839045 | Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection. |
Q51503137 | Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction. |
Q41281344 | B-type natriuretic peptide predicts long-term prognosis in a cohort of critically ill patients |
Q42710195 | Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity |
Q45964336 | Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial. |
Q83426306 | Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy |
Q90291256 | Bone marrow mesenchymal stem cell-derived exosomes protect against myocardial infarction by promoting autophagy |
Q83217859 | CT angiography; no collateral damage |
Q53374687 | CT angiography; useful in non-selected outpatients? |
Q42856734 | CT perfusion angiography; beware of artifacts! |
Q34649009 | CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population |
Q37473732 | Can cardiac computed tomography predict cardiovascular events in asymptomatic type-2 diabetics?: results of a long term follow-up |
Q26853640 | Can lipoprotein-associated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome? |
Q38216215 | Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX). |
Q52985157 | Cardiac CT assessment of left ventricular mass in mid-diastasis and its prognostic value. |
Q92179634 | Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting |
Q64245221 | Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction |
Q35856435 | Cardiac biomarkers in the intensive care unit |
Q51794706 | Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality. |
Q84597610 | Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy |
Q33810087 | Cardiac troponin and cerebral herniation in acute intracerebral hemorrhage |
Q47671109 | Cardiac troponins: from myocardial infarction to chronic disease. |
Q38508938 | Cardiotoxicity due to Chemotherapy: the Role of Biomarkers |
Q40534054 | Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience |
Q37424605 | Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? |
Q36768477 | Carotid intima-media thickness in young survivors of acute myocardial infarction |
Q55392780 | Case fatality ratios for serious emergency conditions in the Republic of Ireland: a longitudinal investigation of trends over the period 2002-2014 using joinpoint analysis. |
Q38869886 | Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality |
Q26765916 | Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration |
Q52643133 | Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. |
Q40033812 | Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997-2010. |
Q57101333 | Characteristics and management of acute ST-segment elevation myocardial infarctions occurring in ski resorts in the French Alps: Impact of an acute coronary care network |
Q37473142 | Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction |
Q57477200 | Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study |
Q35290689 | Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction |
Q33672818 | Clinical characteristics and outcomes of patients with myocarditis mimicking ST-segment elevation myocardial infarction: Analysis of a case series |
Q47926476 | Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. |
Q34204883 | Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up |
Q37454956 | Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland |
Q36540406 | Clinical features of myocardial infarction and myocarditis in young adults: a retrospective study. |
Q34014530 | Clinical implication of coronary tortuosity in patients with coronary artery disease |
Q36644752 | Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome |
Q38102533 | Clinical implications of the Third Universal Definition of Myocardial Infarction |
Q64974769 | Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome. |
Q35731045 | Cocaine use does not affect mean platelet volume |
Q36301931 | Cohort Profile: the Corogene study |
Q49169613 | Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department. |
Q28546788 | Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent |
Q43565621 | Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial |
Q37202126 | Comparative value of simple inflammatory markers in the prediction of left ventricular systolic dysfunction in postacute coronary syndrome patients. |
Q31138335 | Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage |
Q36555021 | Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction |
Q36578419 | Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes |
Q45359342 | Comparison of cardiogoniometry and ECG at rest versus myocardial perfusion scintigraphy. |
Q35331615 | Comparison of clinical outcomes of hydrophilic and lipophilic statins in patients with acute myocardial infarction |
Q89119253 | Comparison of clinical risk scores for triaging high-risk chest pain patients at the emergency department |
Q28641211 | Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries |
Q58088773 | Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes |
Q34179703 | Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction |
Q35131648 | Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients. |
Q37141021 | Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients |
Q50852806 | Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and |
Q36961770 | Comprehensive quality of discharge summaries at an academic medical center |
Q27315149 | Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiography |
Q26829251 | Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding |
Q37221845 | Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). |
Q53733243 | Continuous ECG Monitoring in Patients With Acute Coronary Syndrome or Heart Failure: EASI Versus Gold Standard. |
Q37871924 | Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability |
Q37682501 | Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization |
Q38136336 | Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs |
Q55002418 | Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome. |
Q38220601 | Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia? |
Q35861587 | Coronary dominance and prognosis in patients undergoing coronary computed tomographic angiography: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) registry |
Q38631031 | Coronary dominance and prognosis in patients with chronic total occlusion treated with percutaneous coronary intervention. |
Q27026525 | Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
Q34781673 | Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting |
Q35670489 | Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis |
Q37377798 | Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort |
Q38028866 | Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea. |
Q38933669 | Daily Lowest Hemoglobin and Risk of Organ Dysfunctions in Critically Ill Patients |
Q34304750 | Daylight savings time and myocardial infarction |
Q64891127 | Derivation and validation of a prediction score for acute kidney injury secondary to acute myocardial infarction in Chinese patients. |
Q36727235 | Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). |
Q50065243 | Detecting myocardial infarction type 2: targetting the right patients |
Q36042620 | Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction |
Q35739989 | Developments in the invasive diagnostic-therapeutic cascade of women and men with acute coronary syndromes from 2005 to 2011: a nationwide cohort study |
Q64289545 | Diagnosis and Management of an Inferior ST-elevation Myocardial Infarction: A Simulation Scenario |
Q35940654 | Diagnosis of Coronary Heart Diseases Using Gene Expression Profiling; Stable Coronary Artery Disease, Cardiac Ischemia with and without Myocardial Necrosis |
Q37291917 | Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. |
Q33773201 | Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome |
Q26746722 | Diagnostic algorithms for acute coronary syndrome-is one better than another? |
Q33613089 | Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study |
Q87146986 | Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain study |
Q37425286 | Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. |
Q53491332 | Differences in ward-to-cath lab systolic blood pressure predicts long-term adverse outcomes after drug-eluting stent implantation. |
Q41954032 | Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome |
Q42679244 | Differential expression of B-type natriuretic peptide between left and right ventricles, with particular regard to sudden cardiac death |
Q43953904 | Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry |
Q44656194 | Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems |
Q47903182 | Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not. |
Q59208809 | Does Continuous ST-Segment Monitoring Add Prognostic Information to the TIMI, PURSUIT, and GRACE Risk Scores? |
Q50668373 | Does longitudinal strain predict left ventricular remodeling after myocardial infarction? |
Q22242892 | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) |
Q55037705 | Early and long-term outcomes of complete revascularization with percutaneous coronary intervention in patients with multivessel coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes. |
Q50217429 | Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin |
Q40771637 | Early invasive versus early conservative strategy in non-ST-elevation acute coronary syndrome: An outcome research study. |
Q36797852 | Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention |
Q34541855 | Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS) |
Q44007391 | Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention. |
Q34207158 | Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands |
Q41188685 | Effect of smoking status on coronary artery disease among Chinese post-menopausal women |
Q43722133 | Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis |
Q47988864 | Effectiveness of a cardiac surgery-specific transfusion protocol. |
Q48554961 | Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal Glucose Tolerance. |
Q92241544 | Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial |
Q44876601 | Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction. |
Q43128990 | Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial |
Q37151370 | Efficacy of coronary revascularization in patients with acute chest pain managed in a chest pain unit |
Q37856195 | Egg consumption and risk of cardiovascular disease in the SUN Project |
Q83568984 | Electrocardiographic findings and myocardial damage in acute myocarditis detected by cardiac magnetic resonance |
Q43294342 | Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients |
Q33166211 | Elevated Troponin I in the Absence of Coronary Artery Disease: A Case Report With Review of Literature |
Q35674364 | Endothelial Injury Associated with Cold or Warm Blood Cardioplegia during Coronary Artery Bypass Graft Surgery |
Q96303042 | Enhancement of label-free biosensing of cardiac troponin I |
Q35005369 | Estimated Glomerular Filtration Rate in Short-Risk Stratification in Acute Myocardial Infarction. |
Q37291921 | Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries |
Q85213714 | European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes |
Q45173223 | Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up. |
Q37755114 | Evaluating the role of elevated levels of troponin in acute ischemic stroke |
Q44506632 | Evaluation of analytical performance of the Pathfast cardiac troponin I. |
Q48567121 | Evaluation of beat-to-beat ventricular repolarization lability from standard 12-lead ECG during acute myocardial ischemia |
Q36270066 | Evaluation of early interventional treatment opportunity of the elderly & high-risk patients with non-ST segment elevation acute myocardial infarction |
Q51837358 | Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. |
Q57065396 | Factors associated with delayed hospital arrival among patients with acute myocardial infarction: a cross-sectional study in Greece |
Q36134566 | Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction. |
Q47712900 | Female gender doubles pre-hospital delay times for patients experiencing ST segment elevation myocardial infarction in Saudi Arabia |
Q42922467 | Fingertip digital thermal monitoring: a fingerprint for cardiovascular disease? |
Q38572086 | Fluid Restriction During Pancreaticoduodenectomy: Is It Effective in Reducing Postoperative Complications? |
Q42870481 | Fractional flow reserve application in everyday practice: adherence to clinical recommendations |
Q40793052 | Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients. |
Q46800270 | Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting |
Q39821542 | Frontline diagnostic evaluation of patients suspected of angina by coronary computed tomography reduces downstream resource utilization when compared to conventional ischemia testing. |
Q38647581 | GDF-15 predicts cardiovascular events in acute chest pain patients. |
Q47164229 | Gap in gender parity: gender disparities in incidence and clinical impact of chronic total occlusion in non-infarct artery in patients with non-ST-segment elevation myocardial infarction and multivessel coronary artery disease |
Q34347046 | Gated myocardial SPECT imaging; true additional value in AMI? |
Q36306613 | Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study |
Q36686301 | Gender differences in association between metabolic syndrome and carotid intima media thickness |
Q53061328 | Gender differences in correlates of troponin assay in diagnosis of myocardial infarction. |
Q54617131 | Gender differences in serum CK-MB mass levels in healthy Brazilian subjects. |
Q47120408 | Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland |
Q38390243 | Gender-specific uncertainties in the diagnosis of acute coronary syndrome. |
Q35824246 | Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population |
Q34318279 | Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction |
Q48453082 | Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study |
Q85066486 | Growth differentiation factor 15 in different stages of heart failure: potential screening implications |
Q43284567 | Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery |
Q57245270 | Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca |
Q57243422 | Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST |
Q53363035 | Heart attack guidance for physicians: When to suspect, how to diagnose, what to do? |
Q40390419 | Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010. |
Q36426643 | Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain |
Q36997386 | Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure |
Q51330574 | Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose. |
Q44822548 | Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome |
Q86971780 | Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction |
Q36205878 | High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention |
Q84538472 | High sensitivity troponin in chest pain and acute coronary syndromes. A step forward? |
Q85212685 | High sensitivity troponins and better patient care |
Q58603279 | High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study |
Q34674934 | High-resolution 12-lead electrocardiograms of on-duty professional firefighters: a pilot feasibility study |
Q48540294 | High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis |
Q35648924 | High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy |
Q36974321 | High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice? |
Q37036975 | High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study |
Q37926596 | High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department |
Q48149378 | Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism |
Q36828022 | Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study |
Q39115994 | How should clinicians interpret cardiac troponin values in patients with ESRD? |
Q58314226 | How to use high-sensitivity cardiac troponins in acute cardiac care |
Q39225029 | Hyoscine-N-butyl-bromide-induced hypotension and myocardial ischemia |
Q59652458 | Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac m |
Q64101045 | IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome |
Q46136203 | Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years |
Q37594513 | Impact of High Risk for Obstructive Sleep Apnea on Survival after Acute Coronary Syndrome: Insights from the ERICO Registry |
Q35739774 | Impact of Intercellular Adhesion Molecule-1 Genetic Polymorphisms on Coronary Artery Disease Susceptibility in Taiwanese Subjects |
Q52603881 | Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia. |
Q44828860 | Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes. |
Q44936093 | Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention |
Q33975575 | Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study |
Q33671080 | Impact of perioperative acute ischemic stroke on the outcomes of noncardiac and nonvascular surgery: a single centre prospective study |
Q44774947 | Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme. |
Q55071502 | Impact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention. |
Q35842008 | Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study |
Q35128758 | Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery |
Q43545029 | Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease |
Q50849590 | Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited. |
Q46380285 | Implications of the universal definition of myocardial infarction |
Q60722947 | Implicações prognósticas da pressão telediastólica do ventrículo esquerdo nas síndromes coronárias agudas com fracção de ejecção maior ou igual a 40% |
Q38025446 | Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel |
Q50094174 | Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. |
Q35822223 | Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country |
Q36053300 | Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study |
Q50577959 | Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012). |
Q64066315 | Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction |
Q40494505 | Increased accuracy in computed tomography coronary angiography; a new body surface area adapted protocol |
Q84912378 | Increased aortic stiffness can predict perioperative cardiovascular outcomes in patients undergoing noncardiac, nonvascular surgery |
Q46090017 | Increased ischaemia modified albumin following coronary artery bypass grafting |
Q35107777 | Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study |
Q35121147 | Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFI |
Q49609058 | Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals. |
Q36537308 | Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus |
Q34341707 | Incremental prognostic value of left ventricular function analysis over non-invasive coronary angiography with multidetector computed tomography |
Q40362953 | Induction of a chronic myocardial infarction in the laboratory animal - experimental model |
Q37414864 | Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study. |
Q84153015 | Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study |
Q36549998 | Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging. |
Q37279845 | Inflammatory Cytokines as Risk Factors for Mortality After Acute Cardiac Events |
Q51371087 | Influence of abnormal fasting plasma glucose on left ventricular function in older patients with acute myocardial infarction. |
Q53256527 | Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography. |
Q34632431 | Interaction of type 2 diabetes mellitus with chromosome 9p21 rs10757274 polymorphism on the risk of myocardial infarction: a case-control study in Chinese population |
Q55470760 | Interleukin-6 contributes to myocardial damage in pregnant rats with reduced uterine perfusion pressure. |
Q49913486 | Interphysician agreement on subclassification of myocardial infarction |
Q58230148 | Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention |
Q30467896 | Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes |
Q36307110 | Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study |
Q36099107 | Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery |
Q35681010 | Kinetics of plasma microRNA-499 expression in acute myocardial infarction |
Q38651014 | Lack of association between cystatin C and different coronary atherosclerotic manifestations. |
Q36656914 | Lack of cardioprotection by single-dose magnesium prophylaxis on isoprenaline-induced myocardial infarction in adult Wistar rats |
Q37323623 | Lack of consensus in biomarker measurement to diagnose PCI-related myocardial infarction |
Q92947255 | Long noncoding RNA MALAT1 promotes cardiomyocyte apoptosis after myocardial infarction via targeting miR-144-3p |
Q50019585 | Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry |
Q47317898 | Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial. |
Q40050071 | Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes |
Q36102162 | Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population |
Q53141320 | MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale. |
Q48167674 | MMP1 and MMP3 gene polymorphisms in patients with acute coronary syndromes |
Q41896943 | Magnetic resonance imaging characterization of circumferential and longitudinal strain under various coronary interventions in swine |
Q37606146 | Management of ST-segment elevation myocardial infarction in predominantly rural central China: A retrospective observational study |
Q22242896 | Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: |
Q37040319 | Measurement of cardiac troponins to detect myocardial infarction using high-sensitivity assays: South African guidelines. |
Q36331410 | Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge. |
Q47917702 | Mediterranean diet and prognosis of first-diagnosed Acute Coronary Syndrome patients according to heart failure phenotype: Hellenic Heart Failure Study |
Q46374324 | Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction |
Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
Q45370584 | Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease |
Q37496035 | Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADS |
Q47979579 | Mid-term outcomes of consecutive 998 cases of coronary atherectomy in contemporary clinical practice. |
Q35936345 | Mild functional ischemic mitral regurgitation following acute coronary syndrome: a retrospective study |
Q45990491 | Minor myocardial damage during percutaneous coronary intervention does not affect long-term prognosis. |
Q51772665 | Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study. |
Q38443781 | Modification to the injection needle to a screw needle improves effective cell delivery in acute myocardial infarction |
Q43520766 | Modified TIMI risk score cannot be used to identify low-risk chest pain in the emergency department: a multicentre validation study |
Q41564278 | Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients |
Q36595291 | Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention |
Q34962673 | Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition |
Q55117051 | Myocardial infarction and alcohol consumption: A case-control study. |
Q35827555 | Myocardial infarction in patients over 90 years of age. |
Q35806730 | Myocardial infarction in the elderly |
Q37087148 | Myocardial infarction with normal coronary arteries: a case report and review of the literature |
Q87878929 | NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department |
Q38034812 | Nanomedicine in cardiovascular therapy: recent advancements |
Q34160755 | Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study |
Q34029108 | Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people |
Q42122643 | Nitrate-induced paradoxical ischemia predicts adverse outcomes in elderly patients with healed myocardial infarcts |
Q59329014 | Nocturnal respiratory rate as a predictor of mortality in patients with acute coronary syndrome |
Q45252930 | Non-significant left main disease; truly non-significant? |
Q57481611 | Nonspecific electrocardiographic abnormalities are associated with increased length of stay and adverse cardiac outcomes in prehospital chest pain |
Q34804612 | Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. |
Q58812220 | Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes |
Q87103170 | Observational Study of Chinese Medicine Syndrome Distribution in Patients with Acute Myocardial Infarction and Its Impact on Prognosis |
Q26822387 | Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! |
Q44187961 | Occupation- and age-related differences in work absence due to frequent cardiovascular diseases using essential hypertension and acute myocardial infarction as examples |
Q43241028 | Off-pump coronary surgery causes immediate release of myocardial damage markers |
Q35911633 | One-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study |
Q30487537 | Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine |
Q35684923 | Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction |
Q44799286 | Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction |
Q35926521 | Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes |
Q36168222 | Outcome of cardiac surgery in patients with low preoperative ejection fraction. |
Q35179910 | Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014. |
Q37291929 | Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI). |
Q50864248 | Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b |
Q47729211 | Outcomes of direct stenting in patients with ST-elevated myocardial infarction |
Q37077532 | Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions |
Q34083836 | Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology? |
Q35901123 | PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR |
Q39521563 | Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow |
Q47256572 | Panoramic ECG display versus conventional ECG: ischaemia detection by critical care nurses |
Q38626782 | Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments. |
Q58565462 | Percutaneous coronary intervention in patients with acute coronary syndrome in Chinese Military Hospitals, 2011-2014: a retrospective observational study of a national registry |
Q35989825 | Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry. |
Q34280264 | Performance of the high-sensitivity troponin assay in diagnosing acute myocardial infarction: systematic review and meta-analysis |
Q34147112 | Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. |
Q42028649 | Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice |
Q22241918 | Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention |
Q53326948 | Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. |
Q37434061 | Perspective on the clinical application of troponin in heart failure and states of cardiac injury |
Q46162060 | Pharmacological stress: a useful exercise? |
Q84983360 | Placental Growth Factor as Short-Term Predicting Biomarker in Acute Coronary Syndrome Patients with Non-ST Elevation Myocardial Infarction |
Q45899768 | Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome. |
Q38667602 | Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial |
Q37742114 | Point-of-care testing in critical care: the clinician's point of view |
Q34499457 | Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach |
Q34551196 | Possible regulatory roles of promoter g-quadruplexes in cardiac function-related genes - human TnIc as a model. |
Q35794559 | Post-Acute Coronary Syndrome Alcohol Abuse: Prospective Evaluation in the ERICO Study |
Q30410183 | Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference |
Q37641320 | Prasugrel: a critical comparison with clopidogrel. |
Q37579188 | Prasugrel: a review of its use in patients with acute coronary syndromes undergoing percutaneous coronary intervention |
Q36017226 | Pre-hospital delay in patients with first time myocardial infarction: an observational study in a northern Swedish population |
Q40630060 | Preclinical fibrinolysis in patients with ST-segment elevation myocardial infarction in a rural region |
Q51814247 | Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. |
Q33552596 | Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus. |
Q51504036 | Predictive value of preoperative electrocardiography for perioperative cardiovascular outcomes in patients undergoing noncardiac, nonvascular surgery. |
Q51826589 | Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress. |
Q36392124 | Predictors of Delay in Seeking Health Care among Myocardial Infarction Patients, Minia District, Egypt |
Q35674008 | Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins. |
Q46077941 | Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience |
Q35834663 | Prehospital 12-lead ST-segment monitoring improves the early diagnosis of acute coronary syndrome |
Q37050300 | Prehospital electrocardiographic manifestations of acute myocardial ischemia independently predict adverse hospital outcomes |
Q40219998 | Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry |
Q40401637 | Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypass. |
Q40704357 | Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction. |
Q86476754 | Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis |
Q30976231 | Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort |
Q48693596 | Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels |
Q48103275 | Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry. |
Q35644244 | Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? |
Q45212848 | Prognosis of Vascular Surgery Patients Using a Quantitative Assessment of Troponin T Release: Is the Crystal Ball still Clear? |
Q55278810 | Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome☆. |
Q40873832 | Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study. |
Q38084414 | Prognostic relevance of PCI-related myocardial infarction. |
Q37090512 | Prognostic value of circulating chromogranin A levels in acute coronary syndromes |
Q53172520 | Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography. |
Q53109764 | Prognostic value of dual-source multidetector computed tomography coronary angiography in patients with stent implantation. |
Q43673479 | Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. |
Q53668508 | Progressively heterogeneous mismatch of regional oxygen delivery to consumption during graded coronary stenosis in pig left ventricle. |
Q55053682 | Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1). |
Q38821710 | Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study |
Q37798014 | Proteomic biomarkers for diagnosis in acute myocardial infarction. |
Q37333171 | Quality of discharge practices and patient understanding at an academic medical center |
Q89144385 | Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review |
Q89793591 | Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV |
Q50096658 | Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial |
Q48092260 | Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial. |
Q33737783 | Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a population-based cohort study in the Netherlands |
Q90670056 | Real-Time in Vivo Photoacoustic Imaging in the Assessment of Myocardial Dynamics in Murine Model of Myocardial Ischemia |
Q34364949 | Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction. |
Q53330994 | Recanalization of chronic total coronary occlusions--high success rate despite a restrictive use of the retrograde approach. |
Q35626702 | Recent advances in the diagnosis and treatment of acute myocardial infarction |
Q58314269 | Recommendations for the use of cardiac troponin measurement in acute cardiac care |
Q36439280 | Recurrent intraoperative silent ST depression responding to phenylephrine. |
Q42361221 | Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases. |
Q92604593 | Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax |
Q39313104 | Regional ejection fraction and regional area strain for left ventricular function assessment in male patients after first-time myocardial infarction |
Q34621168 | Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention |
Q55405593 | Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study. |
Q33837952 | Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus |
Q37292090 | Relationship of levels of Vitamin D with flow-mediated dilatation of brachial artery in patients of myocardial infarction and healthy control: A case-control study |
Q44070722 | Reliable exclusion of acute coronary syndrome among hospitalized patients with elevated troponin |
Q37231841 | Repolarization Heterogeneity of Magnetocardiography Predicts Long-Term Prognosis in Patients with Acute Myocardial Infarction |
Q50450876 | Republished: clinical implications of the third universal definition of myocardial infarction. |
Q37448924 | Review of the treatment of acute coronary syndrome in elderly patients |
Q38373055 | Review on cardiovascular risk prediction |
Q92133268 | Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice |
Q92889526 | Right ventricular dysfunction and associated factors in patients after coronary artery bypass grafting |
Q58919482 | Right ventricular function predicts cardiovascular events in outpatients with stable cardiovascular diseases: preliminary results |
Q36649949 | Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis |
Q89983727 | Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery |
Q40540721 | Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. |
Q28253329 | Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial |
Q42366803 | Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD) |
Q48122977 | Role of residual acute stent malapposition in percutaneous coronary interventions |
Q47679974 | ST Depression, No ST Change, or ST Elevation in Inferior Derivations: Which Has the Worst Outcomes in Acute Anterior Myocardial Infarction |
Q38595403 | ST-elevation myocardial infarction following systemic inflammatory response syndrome |
Q85246984 | ST-elevation myocardial infarction in octogerians |
Q35195966 | ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data |
Q64231843 | Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study |
Q38894581 | Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial |
Q40021275 | Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention |
Q35130613 | Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study |
Q34451008 | Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality |
Q45278231 | Serial high-sensitivity troponin measurements for the rapid exclusion of acute myocardial infarction in low-risk patients |
Q39832237 | Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy |
Q50582259 | Serum cardiac troponin T in asphyxiated term neonates delivered at two teaching hospitals in lagos, Nigeria. |
Q43050348 | Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: the Hellenic Heart Failure Study |
Q36318249 | Serum relaxin levels as a novel biomarker for detection of acute myocardial infarction |
Q52677069 | Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis. |
Q44984251 | Should we improve the management of NSTEMI? Results from the population-based "acute myocardial infarction in Florence 2" (AMI-Florence 2) registry |
Q33741680 | Significance of Platelet Volume Indices in STEMI Patients: A Case-Control Study |
Q58814886 | Sinus Rhythm ECG Criteria Associated with Basal-Lateral Ventricular Tachycardia Substrate in Patients with Nonischemic Cardiomyopathy |
Q52886547 | Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a). |
Q26828732 | Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention |
Q37830185 | Spontaneous retrograde dissection of ascending aorta from descending thoracic aorta--a case review |
Q36941995 | Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction |
Q86944045 | Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitable |
Q24193862 | Statins for acute coronary syndrome |
Q24236697 | Statins for acute coronary syndrome |
Q34729472 | Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins. |
Q53362662 | Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. |
Q34909801 | Study of serum sodium and potassium in acute myocardial infarction |
Q37236462 | Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study |
Q35119321 | Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population |
Q33705509 | Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study |
Q36983754 | Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway |
Q55455435 | Synthesis and Characterization of Injectable Hydrogels with Varying Collagen⁻Chitosan⁻Thymosin β4 Composition for Myocardial Infarction Therapy. |
Q41388982 | T-Wave Alternans Is Linked to Microvascular Obstruction and to Recurrent Coronary Ischemia After Myocardial Infarction |
Q38187499 | Takotsubo cardiomyopathy: how much do we know of this syndrome in children and young adults? |
Q37445883 | Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients |
Q60920257 | Tegafur deteriorates established cardiovascular atherosclerosis in colon cancer: A case report and review of the literature |
Q92143395 | Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study |
Q27007476 | The "smoker's paradox" in patients with acute coronary syndrome: a systematic review |
Q64987012 | The Association between Arterial Oxygen Tension, Hemoglobin Concentration, and Mortality in Mechanically Ventilated Critically Ill Patients. |
Q37704006 | The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia |
Q40115007 | The Glider registry. |
Q89683138 | The Impact of the Circadian Genes CLOCK and ARNTL on Myocardial Infarction |
Q51541681 | The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation. |
Q58819391 | The Significance of Heart Rate Turbulence in Predicting Major Cardiovascular Events in Patients after Myocardial Infarction Treated Invasively |
Q92274408 | The Trend in Incidence and Case-fatality of Hospitalized Acute Myocardial Infarction Patients in Korea, 2007 to 2016 |
Q30858405 | The adverse association of diabetes with risk of first acute myocardial infarction is modified by physical activity and body mass index: prospective data from the HUNT Study, Norway. |
Q47929667 | The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction |
Q28743287 | The challenge of triaging chest pain patients: the bernese university hospital experience |
Q37326736 | The clinical impact of the universal diagnosis of myocardial infarction |
Q34973148 | The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort study |
Q35786724 | The effect of changing diagnostic algorithms on acute myocardial infarction rates |
Q55105375 | The effect of periodontal therapy on neopterin and vascular cell adhesion molecule-1 levels in chronic periodontitis patients with and without acute myocardial infarction: a case-control study. |
Q45172938 | The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial |
Q42013589 | The effects of preceding exercise on myocardial damage in rats |
Q54383406 | The effects of running a 308 km ultra-marathon on cardiac markers. |
Q34640836 | The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery |
Q38053481 | The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day. |
Q30397739 | The evolving epidemiology of acute coronary syndromes |
Q46150148 | The impact of modern noninvasive cardiac imaging on coronary intervention rates |
Q37980369 | The influence of heparin resistance on postoperative complications in patients undergoing coronary surgery |
Q64065962 | The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction |
Q44452071 | The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. |
Q38192684 | The mystifying nomenclature of cardiac troponin immunoassays |
Q35599975 | The paradox of the 21st century - is there really an epidemic of most common killers? |
Q38788956 | The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin |
Q36839334 | The prognostic significance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndrome |
Q42152808 | The prospect of serum magnesium and an electrolyte panel as an adjuvant cardiac biomarker in the management of acute myocardial infarction |
Q64096520 | The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat |
Q44799995 | The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX Score |
Q53473296 | The relationship between revascularization extent and the long-term prognosis of patients with stable angina pectoris and three-vessel disease treated by percutaneous coronary intervention in the era of drug-eluting stents. |
Q38678293 | The role of GST polymorphism in reperfusion induced oxidative stress, inflammatory responses and clinical complications after surgical and percutaneous coronary intervention |
Q47130496 | The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome |
Q37815453 | The role of cardiac electrophysiology in myocardial regenerative stem cell therapy |
Q48264224 | The role of religious faith, spirituality and existential considerations among heart patients in a secular society: relation to depressive symptoms 6 months post acute coronary syndrome |
Q35667272 | The rs12526453 Polymorphism in an Intron of the PHACTR1 Gene and Its Association with 5-Year Mortality of Patients with Myocardial Infarction |
Q39734002 | The universal 2012 definition of myocardial infarction compared to the 2007 definition |
Q34295914 | Third universal definition of myocardial infarction |
Q57314061 | Third universal definition of myocardial infarction |
Q36474491 | Thirty-day rehospitalizations after acute myocardial infarction: a cohort study |
Q38049324 | Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays |
Q33922443 | Transient ischemic attack: definition, diagnosis, and risk stratification |
Q61671340 | Tratamiento extrahospitalario y en Urgencias del síndrome coronario agudo con elevación persistente del segmento ST |
Q47960202 | Treatment of patients with myocardial infarction depends on history of cancer |
Q92792135 | Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction |
Q37463805 | Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment |
Q59684149 | Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation |
Q24630238 | Troponin elevation in conditions other than acute coronary syndromes |
Q37822227 | Troponin elevation in coronary vs. non-coronary disease |
Q28269814 | Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section |
Q37323094 | Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting |
Q37289429 | Troponin revisited 2008: assay performance |
Q36282559 | Troponin: think before you request one |
Q82300584 | Troponins and high-sensitivity troponins as markers of necrosis in CAD and heart failure |
Q46396768 | Type 2 myocardial infarction in clinical practice |
Q41598744 | Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies |
Q35083354 | Type-II myocardial infarction--patient characteristics, management and outcomes |
Q38209902 | Universal MI definition update for cardiovascular disease |
Q46583094 | Unprotected left main coronary artery disease after revascularization : effect of diabetes on patient outcomes |
Q86517375 | Unrecognised myocardial infarction in patients with schizophrenia |
Q34561430 | Unusual case of severe arrhythmia developed after acute intoxication with tosylchloramide. |
Q58919752 | Update on the Universal Definition of Acute Myocardial Infarction in the Light of New Data |
Q33695847 | Updated electrocardiographic classification of acute coronary syndromes |
Q83204612 | Uric acid in the early risk stratification of ST-elevation myocardial infarction |
Q39282279 | Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease |
Q51767834 | Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study. |
Q42687692 | Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial |
Q34769171 | Use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study |
Q41548739 | Use of the anterior-posterior chest diameter in CT: reduction in radiation dose? |
Q54496682 | Validation of the Vancouver Chest Pain Rule: a prospective cohort study. |
Q38441999 | Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. |
Q92305993 | Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction |
Q90394825 | Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis |
Q24234883 | Vasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary intervention |
Q36738245 | Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome |
Q45180417 | Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial |
Q36324183 | Vulnerabilities to Temperature Effects on Acute Myocardial Infarction Hospital Admissions in South Korea |
Q53822441 | Weather and risk of ST-elevation myocardial infarction revisited: Impact on young women. |
Q41904786 | Welcome to the ESC journal family |
Q34624212 | World Health Organization definition of myocardial infarction: 2008-09 revision |
Q24635956 | Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study |
Q41559941 | Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial |
Q51132112 | [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]. |
Q83474563 | [Cardiac biomarkers in the critically ill] |
Q83695863 | [Cardiogenic shock] |
Q86312717 | [Cardiogenic shock] |
Q50868028 | [Interaction between heart and brain in sudden cardiac death]. |
Q81721527 | [Interventional therapy of acute myocardial infarction] |
Q83189216 | [STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?] |
Q83250042 | [Update on ischemic heart disease] |
Search more.